What are Transplant & Cellular Therapies?

Transplant and cellular therapies (TCT) are fast-evolving, life-saving treatments using a patient’s own cells—or donor cells. They are mainly indicated in malignant diseases like leukemia, lymphoma, and multiple myeloma.

These treatments are booming.

Some of them, like “CAR-T therapy, have been considered a major breakthrough in cancer immunotherapy, owing to treatment response rates observed in even heavily pretreated patients." (Source: JCO Oncology Practice, 2023. "Operationalizing CAR-T Therapy in Clinical Practice: Challenges and Opportunities.")

But so is the complexity of delivering them.

⚡️ Coordinating care across multiple departments.

⚡️ Manually scheduling through spreadsheets

⚡️ Adjusting operations to frequent changes in care trajectories

⚡️ No visibility into downstream impact of operational decisions

The consequences:

👴 For patients: Limited access to live-saving therapies.

👩‍⚕️ For staff: Stress and administrative burden leading to burnout.

 🏥 For centers: Wasted capacity, affecting financial performance and ability to deliver quality care.

So we’ve decided to bring what we do best:

✅ Smart scheduling automation

✅ Capacity optimization management 

✅ Real-time orchestration across departments

✅ Ops intelligence and predictive analytics

Because

🌍 We dream of a healthcare system where no resources are wasted — and where every patient has equitable access to care, no matter the disease;

🔁 The challenges we tackle go beyond a single service line — they’re part of delivering  high-quality, patient-centered, integrated care;

 💫 And because from day one, our platform was designed to scale across departments, locations... and diseases.